Fu L, Zhou X, Zhang X, Li X, Zhang F, Gu H
J Hematol Oncol. 2025; 18(1):29.
PMID: 40069858
PMC: 11900646.
DOI: 10.1186/s13045-025-01673-7.
Knoppers T, Haley C, Bouhouita-Guermech S, Hagan J, Bradbury-Jost J, Alarie S
PLoS One. 2024; 19(4):e0302156.
PMID: 38635542
PMC: 11025855.
DOI: 10.1371/journal.pone.0302156.
Huang Z, Fu Y, Yang H, Zhou Y, Shi M, Li Q
Mol Cancer. 2024; 23(1):36.
PMID: 38365716
PMC: 10874034.
DOI: 10.1186/s12943-024-01947-7.
Wang X, Wang L, Lin H, Zhu Y, Huang D, Lai M
Front Oncol. 2024; 14:1303335.
PMID: 38333685
PMC: 10850354.
DOI: 10.3389/fonc.2024.1303335.
Shuai Y, Ma Z, Ju J, Wei T, Gao S, Kang Y
J Transl Med. 2023; 21(1):809.
PMID: 37957623
PMC: 10644618.
DOI: 10.1186/s12967-023-04660-z.
Minimal residual disease in solid tumors: an overview.
Ma Y, Gan J, Bai Y, Cao D, Jiao Y
Front Med. 2023; 17(4):649-674.
PMID: 37707677
DOI: 10.1007/s11684-023-1018-6.
Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies.
Nguyen X, Moekotte L, Plomp A, Bergen A, van Genderen M, Boon C
Int J Mol Sci. 2023; 24(8).
PMID: 37108642
PMC: 10139437.
DOI: 10.3390/ijms24087481.
When Not to Ask: A Defense of Choice-Masking Nudges in Medical Research.
McGrew S, Raskoff S, Berkman B
J Health Care Law Policy. 2023; 25(1):1-48.
PMID: 37034557
PMC: 10078241.
Disruptive technology: Exploring the ethical, legal, political, and societal implications of nanopore sequencing technology: Exploring the ethical, legal, political, and societal implications of nanopore sequencing technology.
Sajeer P M
EMBO Rep. 2023; 24(5):e56619.
PMID: 36988424
PMC: 10157308.
DOI: 10.15252/embr.202256619.
Return of Results in Genomic Research Using Large-Scale or Whole Genome Sequencing: Toward a New Normal.
Wolf S, Green R
Annu Rev Genomics Hum Genet. 2023; 24:393-414.
PMID: 36913714
PMC: 10497726.
DOI: 10.1146/annurev-genom-101122-103209.
Liquid biopsy: current technology and clinical applications.
Nikanjam M, Kato S, Kurzrock R
J Hematol Oncol. 2022; 15(1):131.
PMID: 36096847
PMC: 9465933.
DOI: 10.1186/s13045-022-01351-y.
Whole Exome Sequencing in South Africa: Stakeholder Views on Return of Individual Research Results and Incidental Findings.
Van Der Merwe N, Ramesar R, de Vries J
Front Genet. 2022; 13:864822.
PMID: 35754817
PMC: 9216214.
DOI: 10.3389/fgene.2022.864822.
Returning raw genomic data: rights of research participants and obligations of health care professionals.
Nielsen J, Johnston C, OBrien T, Tyrrell V
Med J Aust. 2022; 216(11):550-552.
PMID: 35643837
PMC: 9328317.
DOI: 10.5694/mja2.51546.
Ethical Challenges Posed by Big Data.
Howe Iii E, Elenberg F
Innov Clin Neurosci. 2021; 17(10-12):24-30.
PMID: 33898098
PMC: 7819582.
Plasma Proteomes Can Be Reidentifiable and Potentially Contain Personally Sensitive and Incidental Findings.
Geyer P, Porsdam Mann S, Treit P, Mann M
Mol Cell Proteomics. 2021; 20:100035.
PMID: 33444735
PMC: 7950134.
DOI: 10.1074/mcp.RA120.002359.
Whole-Genome and Whole-Exome Sequencing in Pediatric Oncology: An Assessment of Parent and Young Adult Patient Knowledge, Attitudes, and Expectations.
Oberg J, Ruiz J, Ali-Shaw T, Schlechtweg K, Ricci A, Kung A
JCO Precis Oncol. 2020; 2.
PMID: 32913997
PMC: 7446494.
DOI: 10.1200/PO.17.00104.
Privacy and ethical challenges in next-generation sequencing.
Martinez-Martin N, Magnus D
Expert Rev Precis Med Drug Dev. 2020; 4(2):95-104.
PMID: 32775691
PMC: 7413244.
DOI: 10.1080/23808993.2019.1599685.
Big Data Privacy in Biomedical Research.
Wang S, Bonomi L, Dai W, Chen F, Cheung C, Bloss C
IEEE Trans Big Data. 2020; 6(2):296-308.
PMID: 32478127
PMC: 7258042.
DOI: 10.1109/TBDATA.2016.2608848.
Revised Common Rule Changes to the Consent Process and Consent Form.
LeCompte L, Young S
Ochsner J. 2020; 20(1):62-75.
PMID: 32284685
PMC: 7122264.
DOI: 10.31486/toj.19.0055.
Return of Value in the New Era of Biomedical Research-One Size Will Not Fit All.
Khodyakov D, Mendoza-Graf A, Berry S, Nebeker C, Bromley E
AJOB Empir Bioeth. 2019; 10(4):265-275.
PMID: 31580791
PMC: 6803105.
DOI: 10.1080/23294515.2019.1666175.